UPDATE : Thursday, May 23, 2019
상단여백
Prosecutors seek arrest warrant of Samsung BioLogics CEO by Lee Han-soo 2019-05-23 11:19
[News Focus] Kolon, regulator rapped for not doing enough to quell concerns of patients by Jeong Sae-im 2019-05-22 11:59
Legislator, activists call for revoking Invossa license, conducting probes by Jeong Sae-im 2019-05-21 16:03
Kolon to follow 3,700 Invossa-treated patients for 15 years by Jeong Sae-im 2019-05-17 15:38
Will Celltrion CEO’s bet on ‘bio valley’ pay off? by Jeong Sae-im 2019-05-17 13:21
라인
CHA Biotech’s operating income plunges 92% in Q1 by Jeong Sae-im 2019-05-16 13:41
KangStem Biotech completes stem cell drug plant by Jeong Sae-im 2019-05-16 11:27
Samsung BioLogics in tight spot amid probe, shareholders’ lawsuit by Jeong Sae-im 2019-05-14 14:10
Celltrion’s operating income down 33% in Q1 by Jeong Sae-im 2019-05-09 15:26
If Invossa license gets revoked, Kolon should return $13 million to Mundipharma by Jeong Sae-im 2019-05-08 15:33
라인
Inspection will clear all suspicions over Invossa: TissueGene by Jeong Sae-im 2019-05-08 14:32
Kolon might have covered up Invossa mislabeling for 2 years by Jeong Sae-im 2019-05-07 15:55
When will regulator visit Kolon TissueGene for inspection? by Lee Hye-seon 2019-05-02 14:09
Civic group files complaint against Kolon, regulator by Jeong Sae-im 2019-04-30 14:59
FDA OKs Celltrion’s antibiotics generic by Lee Han-soo 2019-04-30 11:22
라인
Huons, Genexine to cooperate on biopharmaceuticals by Lee Han-soo 2019-04-29 15:10
Techniques for biobetters get ever more advanced by Jeong Sae-im 2019-04-29 11:48
Prosecutors seek arrest warrant of Samsung Bioepis executives by Lee Han-soo 2019-04-26 17:19
FDA OKs Samsung Bioepis’ Etanercept biosimilar by Lee Han-soo 2019-04-26 14:22
Foreign patients to join class-action suit against Kolon for Invossa by Jeong Sae-im 2019-04-25 15:39
여백
여백
여백
Back to Top